Indefinite Delivery Contract SPE2DU25D3114

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $4,999,999, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, Designated Providers, and Other Government Agencies. The contracted products and services encompass a comprehensive range of pharmaceutical items, including brand-name, generic, and specialty medications, as well as related medical supplies such as syringes, vials, and test kits. The contract has a 30-month base period with three 30-month option periods, for a total potential duration of over 10 years. This is an unrestricted, fully competitive acquisition with multiple primary supplier awards for separate geographic regions, as well as a backup supplier award, to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

The original solicitation, which is expected to be issued in March 2024, will have an estimated total value of $30.3 billion across all regions and suppliers. The award will be made on a lowest price technically acceptable (LPTA) basis, with the government potentially utilizing a reverse auction process to obtain the best distribution fees. Interested vendors are advised to attend a pre-proposal conference to ask questions before submitting their proposals, which will remain open for 45 days after the solicitation is posted.